Results 31 to 40 of about 3,802,616 (346)
Potently neutralizing and protective human antibodies against SARS-CoV-2
Nature, 2020 The ongoing pandemic of coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a major threat to global health1 and the medical countermeasures available so far are limited2,3.
Seth J. Zost +40 more
semanticscholar +1 more source
Single-Cell Technologies for the Study of Antibody-Secreting Cells
Frontiers in Immunology, 2022 Antibody-secreting cells (ASC), plasmablasts and plasma cells, are terminally differentiated B cells responsible for large-scale production and secretion of antibodies.
Matteo Broketa +2 more
doaj +1 more source
Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19
New England Journal of Medicine, 2020 Covid-19 Antibodies after Mild Infection Among 34 volunteers who had recovered from mild Covid-19 illness, antiviral antibodies to the receptor-binding domain of the viral spike protein declined wi...
F. J. Ibarrondo +9 more
semanticscholar +1 more source
Acknowledgement to Reviewers of Antibodies in 2015
Antibodies, 2016 The editors of Antibodies would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2015. [...]
Antibodies Editorial Office
doaj +1 more source
Cells, 2023 Serum amyloid A (SAA) proteins belong to a family of acute-phase reactants, playing an integral role in defending the organism from pathological damage.
Ralfs Buks +6 more
doaj +1 more source
Monoclonal Antibodies in Cancer Therapy
Antibodies, 2020 Monoclonal antibody-based immunotherapy is now considered to be a main component of cancer therapy, alongside surgery, radiation, and chemotherapy. Monoclonal antibodies possess a diverse set of clinically relevant mechanisms of action.
D. Zahavi, L. Weiner
semanticscholar +1 more source
Acknowledgement to Reviewers of Antibodies in 2018
Antibodies, 2019 Peer review is an essential part of the publication process, ensuring that Antibodies maintains high quality standards for its published papers. [...]
Antibodies Editorial Office
doaj +1 more source
How Can Immune Checkpoint Inhibitors Cause Hyperprogression in Solid Tumors?
Frontiers in Immunology, 2020 Following the administration of immune checkpoint inhibitors, an unexpected pattern of response designated as hyperprogression may be observed in certain patients.
Morgane Denis +6 more
doaj +1 more source
Prospective mapping of viral mutations that escape antibodies used to treat COVID-19
bioRxiv, 2020 Antibodies are becoming a frontline therapy for SARS-CoV-2, but the risk of viral evolutionary escape remains unclear. Here we map how all mutations to SARS-CoV-2’s receptor-binding domain (RBD) affect binding by the antibodies in Regeneron’s REGN-COV2 ...
Tyler N. Starr +7 more
semanticscholar +1 more source
BiomedicinesTherapeutic antibodies (Abs) which act on a broader range of epitopes may provide more durable protection against the genetic drift of a target, typical of viruses or tumors.
Ilse Roodink +20 more
doaj +1 more source